vs
Side-by-side financial comparison of Fortive (FTV) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.1B, roughly 1.4× Fortive). Fortive runs the higher net margin — 12.8% vs 4.4%, a 8.3% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 7.7%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -17.0%).
Fortive Corporation is an American industrial technology conglomerate company headquartered in Everett, Washington. The company specializes in providing essential technologies for connected workflow solutions; designing, developing, manufacturing and distributing professional and engineered products, software and services. Their products and services are split into three strategic segments; Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. As of Decem...
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
FTV vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.5B |
| Net Profit | $136.4M | $66.5M |
| Gross Margin | 63.2% | 90.5% |
| Operating Margin | 17.9% | 12.4% |
| Net Margin | 12.8% | 4.4% |
| Revenue YoY | 7.7% | 32.8% |
| Net Profit YoY | 21.1% | 143.8% |
| EPS (diluted) | $0.44 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.0B | $1.4B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $1.1B | ||
| Q4 24 | $1.6B | $1.1B | ||
| Q3 24 | $1.5B | $1.0B | ||
| Q2 24 | $1.6B | $929.2M |
| Q1 26 | $136.4M | — | ||
| Q4 25 | $185.7M | $66.5M | ||
| Q3 25 | $55.0M | $124.8M | ||
| Q2 25 | $166.6M | $94.3M | ||
| Q1 25 | $171.9M | $1.3M | ||
| Q4 24 | $208.8M | $-151.9M | ||
| Q3 24 | $221.6M | $-121.3M | ||
| Q2 24 | $195.1M | $-120.4M |
| Q1 26 | 63.2% | — | ||
| Q4 25 | 63.2% | 90.5% | ||
| Q3 25 | 63.2% | 86.1% | ||
| Q2 25 | 59.0% | 87.5% | ||
| Q1 25 | 59.8% | 85.2% | ||
| Q4 24 | 60.3% | 85.8% | ||
| Q3 24 | 60.0% | 83.0% | ||
| Q2 24 | 59.8% | 85.1% |
| Q1 26 | 17.9% | — | ||
| Q4 25 | 20.1% | 12.4% | ||
| Q3 25 | 15.5% | 11.5% | ||
| Q2 25 | 14.6% | 6.7% | ||
| Q1 25 | 15.8% | 1.0% | ||
| Q4 24 | 19.0% | -7.0% | ||
| Q3 24 | 19.3% | -12.0% | ||
| Q2 24 | 19.4% | -11.5% |
| Q1 26 | 12.8% | — | ||
| Q4 25 | 16.5% | 4.4% | ||
| Q3 25 | 5.4% | 8.8% | ||
| Q2 25 | 11.0% | 7.2% | ||
| Q1 25 | 11.7% | 0.1% | ||
| Q4 24 | 12.9% | -13.5% | ||
| Q3 24 | 14.4% | -12.1% | ||
| Q2 24 | 12.6% | -13.0% |
| Q1 26 | $0.44 | — | ||
| Q4 25 | $0.60 | $0.05 | ||
| Q3 25 | $0.16 | $0.08 | ||
| Q2 25 | $0.49 | $0.06 | ||
| Q1 25 | $0.50 | $0.00 | ||
| Q4 24 | $0.60 | $-0.10 | ||
| Q3 24 | $0.63 | $-0.09 | ||
| Q2 24 | $0.55 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $356.1M | $4.5B |
| Total DebtLower is stronger | $3.5B | $836.4M |
| Stockholders' EquityBook value | $6.1B | $4.4B |
| Total Assets | $11.6B | $8.2B |
| Debt / EquityLower = less leverage | 0.57× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $356.1M | — | ||
| Q4 25 | $375.5M | $4.5B | ||
| Q3 25 | $430.8M | $4.0B | ||
| Q2 25 | $1.8B | $2.8B | ||
| Q1 25 | $892.1M | $2.5B | ||
| Q4 24 | $813.3M | $2.6B | ||
| Q3 24 | $811.3M | $2.7B | ||
| Q2 24 | $644.1M | $2.6B |
| Q1 26 | $3.5B | — | ||
| Q4 25 | $3.2B | $836.4M | ||
| Q3 25 | $3.3B | — | ||
| Q2 25 | $4.8B | — | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $3.7B | — | ||
| Q3 24 | $3.9B | — | ||
| Q2 24 | $3.8B | — |
| Q1 26 | $6.1B | — | ||
| Q4 25 | $6.5B | $4.4B | ||
| Q3 25 | $6.5B | $4.1B | ||
| Q2 25 | $10.4B | $3.8B | ||
| Q1 25 | $10.2B | $3.5B | ||
| Q4 24 | $10.2B | $3.3B | ||
| Q3 24 | $10.6B | $3.4B | ||
| Q2 24 | $10.5B | $3.4B |
| Q1 26 | $11.6B | — | ||
| Q4 25 | $11.7B | $8.2B | ||
| Q3 25 | $11.9B | $7.6B | ||
| Q2 25 | $18.2B | $6.3B | ||
| Q1 25 | $17.1B | $5.8B | ||
| Q4 24 | $17.0B | $5.9B | ||
| Q3 24 | $17.5B | $5.8B | ||
| Q2 24 | $17.3B | $5.7B |
| Q1 26 | 0.57× | — | ||
| Q4 25 | 0.50× | 0.19× | ||
| Q3 25 | 0.51× | — | ||
| Q2 25 | 0.46× | — | ||
| Q1 25 | 0.38× | — | ||
| Q4 24 | 0.36× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $234.8M | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | 2.5% | 2.5% |
| Cash ConversionOCF / Net Profit | 1.72× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $234.8M | — | ||
| Q4 25 | $1.1B | $417.3M | ||
| Q3 25 | $164.4M | $402.6M | ||
| Q2 25 | $311.2M | $263.6M | ||
| Q1 25 | $241.7M | $44.1M | ||
| Q4 24 | $502.2M | $75.2M | ||
| Q3 24 | $459.0M | $188.4M | ||
| Q2 24 | $308.9M | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | $313.8M | $379.8M | ||
| Q3 25 | $153.1M | $354.5M | ||
| Q2 25 | $274.5M | $219.8M | ||
| Q1 25 | $215.0M | $-12.3M | ||
| Q4 24 | $465.2M | $-17.3M | ||
| Q3 24 | $431.2M | $54.7M | ||
| Q2 24 | $279.7M | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | 28.0% | 25.4% | ||
| Q3 25 | 14.9% | 25.1% | ||
| Q2 25 | 18.1% | 16.7% | ||
| Q1 25 | 14.6% | -1.1% | ||
| Q4 24 | 28.7% | -1.5% | ||
| Q3 24 | 28.1% | 5.5% | ||
| Q2 24 | 18.0% | -22.1% |
| Q1 26 | 2.5% | — | ||
| Q4 25 | 2.7% | 2.5% | ||
| Q3 25 | 1.1% | 3.4% | ||
| Q2 25 | 2.4% | 3.3% | ||
| Q1 25 | 1.8% | 5.0% | ||
| Q4 24 | 2.3% | 8.2% | ||
| Q3 24 | 1.8% | 13.3% | ||
| Q2 24 | 1.9% | 11.8% |
| Q1 26 | 1.72× | — | ||
| Q4 25 | 5.83× | 6.28× | ||
| Q3 25 | 2.99× | 3.22× | ||
| Q2 25 | 1.87× | 2.79× | ||
| Q1 25 | 1.41× | 34.71× | ||
| Q4 24 | 2.41× | — | ||
| Q3 24 | 2.07× | — | ||
| Q2 24 | 1.58× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
